-
Something wrong with this record ?
Inhibition of synaptic transmission by anandamide precursor 20:4-NAPE is mediated by TRPV1 receptors under inflammatory conditions
D. Spicarova, V. Nerandzic, D. Muzik, M. Pontearso, A. Bhattacharyya, I. Nagy, J. Palecek
Status not-indexed Language English Country Switzerland
Document type Journal Article
NLK
Directory of Open Access Journals
from 2008
Free Medical Journals
from 2008
PubMed Central
from 2008
Europe PubMed Central
from 2008
ProQuest Central
from 2008-03-28
Open Access Digital Library
from 2008-01-01
Open Access Digital Library
from 2008-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2008
- Publication type
- Journal Article MeSH
Transient receptor potential ion channel, vanilloid subfamily, type 1 (TRPV1) cation channel, and cannabinoid receptor 1 (CB1) are essential in the modulation of nociceptive signaling in the spinal cord dorsal horn that underlies different pathological pain states. TRPV1 and CB1 receptors share the endogenous agonist anandamide (AEA), produced from N-arachidonoylphosphatidylethanolamine (20:4-NAPE). We investigated the effect of the anandamide precursor 20:4-NAPE on synaptic activity in naive and inflammatory conditions. Patch-clamp recordings of miniature excitatory postsynaptic currents (mEPSCs) from superficial dorsal horn neurons in rat acute spinal cord slices were used. Peripheral inflammation was induced by subcutaneous injection of carrageenan. Under naive conditions, mEPSCs frequency (0.96 ± 0.11 Hz) was significantly decreased after 20 μM 20:4-NAPE application (55.3 ± 7.4%). This 20:4-NAPE-induced inhibition was blocked by anandamide-synthesizing enzyme N-acyl phosphatidylethanolamine phospholipase D (NAPE-PLD) inhibitor LEI-401. In addition, the inhibition was prevented by the CB1 receptor antagonist PF 514273 (0.2 μM) but not by the TRPV1 receptor antagonist SB 366791 (10 μM). Under inflammatory conditions, 20:4-NAPE (20 μM) also exhibited a significant inhibitory effect (74.5 ± 8.9%) on the mEPSCs frequency that was prevented by the TRPV1 receptor antagonist SB 366791 but not by PF 514273 application. Our results show that 20:4-NAPE application has a significant modulatory effect on spinal cord nociceptive signaling that is mediated by both TRPV1 and CB1 presynaptic receptors, whereas peripheral inflammation changes the underlying mechanism. The switch between TRPV1 and CB1 receptor activation by the AEA precursor 20:4-NAPE during inflammation may play an important role in nociceptive processing, hence the development of pathological pain.
Department of Physiology University of Debrecen Debrecen Hungary
Laboratory of Pain Research Institute of Physiology of the Czech Academy of Sciences Prague Czechia
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23015868
- 003
- CZ-PrNML
- 005
- 20231020093438.0
- 007
- ta
- 008
- 231010s2023 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3389/fnmol.2023.1188503 $2 doi
- 035 __
- $a (PubMed)37426071
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Spicarova, Diana $u Laboratory of Pain Research, Institute of Physiology of the Czech Academy of Sciences, Prague, Czechia
- 245 10
- $a Inhibition of synaptic transmission by anandamide precursor 20:4-NAPE is mediated by TRPV1 receptors under inflammatory conditions / $c D. Spicarova, V. Nerandzic, D. Muzik, M. Pontearso, A. Bhattacharyya, I. Nagy, J. Palecek
- 520 9_
- $a Transient receptor potential ion channel, vanilloid subfamily, type 1 (TRPV1) cation channel, and cannabinoid receptor 1 (CB1) are essential in the modulation of nociceptive signaling in the spinal cord dorsal horn that underlies different pathological pain states. TRPV1 and CB1 receptors share the endogenous agonist anandamide (AEA), produced from N-arachidonoylphosphatidylethanolamine (20:4-NAPE). We investigated the effect of the anandamide precursor 20:4-NAPE on synaptic activity in naive and inflammatory conditions. Patch-clamp recordings of miniature excitatory postsynaptic currents (mEPSCs) from superficial dorsal horn neurons in rat acute spinal cord slices were used. Peripheral inflammation was induced by subcutaneous injection of carrageenan. Under naive conditions, mEPSCs frequency (0.96 ± 0.11 Hz) was significantly decreased after 20 μM 20:4-NAPE application (55.3 ± 7.4%). This 20:4-NAPE-induced inhibition was blocked by anandamide-synthesizing enzyme N-acyl phosphatidylethanolamine phospholipase D (NAPE-PLD) inhibitor LEI-401. In addition, the inhibition was prevented by the CB1 receptor antagonist PF 514273 (0.2 μM) but not by the TRPV1 receptor antagonist SB 366791 (10 μM). Under inflammatory conditions, 20:4-NAPE (20 μM) also exhibited a significant inhibitory effect (74.5 ± 8.9%) on the mEPSCs frequency that was prevented by the TRPV1 receptor antagonist SB 366791 but not by PF 514273 application. Our results show that 20:4-NAPE application has a significant modulatory effect on spinal cord nociceptive signaling that is mediated by both TRPV1 and CB1 presynaptic receptors, whereas peripheral inflammation changes the underlying mechanism. The switch between TRPV1 and CB1 receptor activation by the AEA precursor 20:4-NAPE during inflammation may play an important role in nociceptive processing, hence the development of pathological pain.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Nerandzic, Vladimir $u Laboratory of Pain Research, Institute of Physiology of the Czech Academy of Sciences, Prague, Czechia
- 700 1_
- $a Muzik, David $u Laboratory of Pain Research, Institute of Physiology of the Czech Academy of Sciences, Prague, Czechia
- 700 1_
- $a Pontearso, Monica $u Laboratory of Pain Research, Institute of Physiology of the Czech Academy of Sciences, Prague, Czechia
- 700 1_
- $a Bhattacharyya, Anirban $u Laboratory of Pain Research, Institute of Physiology of the Czech Academy of Sciences, Prague, Czechia
- 700 1_
- $a Nagy, Istvan $u Section of Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Imperial College London, Faculty of Medicine, Chelsea and Westminster Hospital, London, United Kingdom $u Department of Physiology, University of Debrecen, Debrecen, Hungary
- 700 1_
- $a Palecek, Jiri $u Laboratory of Pain Research, Institute of Physiology of the Czech Academy of Sciences, Prague, Czechia
- 773 0_
- $w MED00163316 $t Frontiers in molecular neuroscience $x 1662-5099 $g Roč. 16, č. - (2023), s. 1188503
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37426071 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20231010 $b ABA008
- 991 __
- $a 20231020093431 $b ABA008
- 999 __
- $a ok $b bmc $g 1997298 $s 1202230
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2023 $b 16 $c - $d 1188503 $e 20230622 $i 1662-5099 $m Frontiers in molecular neuroscience $n Front Mol Neurosci $x MED00163316
- LZP __
- $a Pubmed-20231010